Titlebook: Image-Guided Interventions in Oncology; An Interdisciplinary Christos Georgiades,Hyun S. Kim Book 2020 Springer Nature Switzerland AG 2020

HAWK

放纵

Hepatocellular Carcinoma: Eastern Experience,n established as mainstay modality in unresectable HCC. Superselective catheterization is the most important way to guarantee better outcome and safety of chemoembolization. Recent advancement of cone-beam CT, small caliber microcatheter, and resilient guidewire has made it easier than before. As th

AVID

Intrahepatic Cholangiocarcinoma,re ineligible for curative surgical treatments, and standard systemic therapy confers minimal survival benefits while having significant adverse effects. There is data to support use of palliative intra-arterial therapies (IAT), which have minimal associated toxicities while giving patients a surviv

Ebct207

Colorectal Cancer: Liver Metastatic Disease,t 861,000 deaths in 2018 according to the World Health Organization. At the time of diagnosis, 20–25% of patients will have stage IV disease (1–4) with metastasis to the liver affecting 40% of patients (1). Additionally, 35–60% of CRC patients will develop liver metastases later in the disease proce

一个搅动不安

Entirety

Retrieval

Bone Metastatic Disease,one can act either as definite therapy aiming in local tumor control or as palliative therapies focusing upon pain reduction, providing structural support and tumor decompression. The Interventional Oncology armamentarium for bone metastatic disease includes percutaneous ablation as well as vertebra

虚假

HILAR

Thyroid Cancer, mm in size, categorizing the disease as a subclinical process. The traditional therapeutic option for this patient population was thyroidectomy until active surveillance became a viable alternative to surgical resection. Of the patients that are diagnosed, approximately 50% are unwilling to undergo

上釉彩

Soft Tissue Sarcoma (STS),r focal therapies, such as surgery or radiation therapy, when those treatments either have failed or have been deemed less appropriate. While limited, current data suggest that percutaneous ablation is safe and feasible for soft tissue sarcoma metastases of various histologic subtypes and in diverse